Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Healthy ExtractsHYEX 56 Gross Margin % is 70.25% as of Jun. 2026, which is 26% above its 10-year median of 55.95. GuruFocus rates HYEX with a GF Score™ of 56/100 and a GF Value™ of $1.15 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 938 Drug Manufacturers companies, Healthy Extracts ranks better than 70.04% on this metric.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Healthy Extracts had a gross margin of 70.25% for the quarter that ended in Jun. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Healthy Extracts Gross Margin % Related Terms
Healthy Extracts Gross Margin % Historical Data
* Premium members only.
The historical data trend for Healthy Extracts's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HYEX vs CABR, BFRI, IGPK: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Healthy Extracts's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Healthy Extracts Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Healthy Extracts's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Healthy Extracts's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Healthy Extracts (HYEX) has a Gross Margin % of 70.25% as of Jun. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Healthy Extracts and its competitors. This is 26% above median its historical median of 55.95. According to the industry distribution chart, Healthy Extracts ranks #281 out of 938 companies in the Drug Manufacturers industry, placing it in the top 30%.
Is Healthy Extracts' Gross Margin % too high?
Healthy Extracts' current Gross Margin % of 70.25% is 26% above median its 10-year median of 55.95. The Drug Manufacturers industry median Gross Margin % is 48.44. Healthy Extracts' value of 70.25% is 45% above this industry median. Based on the distribution chart, Healthy Extracts ranks #281 out of 938 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Healthy Extracts has a GF Score™ of 56/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Healthy Extracts' Gross Margin % compare to CABR and BFRI?
According to the Drug Manufacturers industry distribution chart, Healthy Extracts ranks #281 out of 938 companies for Gross Margin %. This puts Healthy Extracts in the upper half of its industry. The industry median Gross Margin % is 48.44. Healthy Extracts' value of 70.25% is 45% above this benchmark. While the company's 10-year median is 55.95 vs. the industry median of 48.44, Healthy Extracts has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.44, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Healthy Extracts's current Gross Margin % of 70.25% is 45% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Healthy Extracts and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Healthy Extracts's current Gross Margin % is 70.25%, which is 26% above median its own 10-year median of 55.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthy Extracts stock overvalued right now?
Based on GuruFocus' analysis, Healthy Extracts (HYEX) is currently considered Modestly Overvalued. The stock's GF Value™ is $1.15, compared to a current price of $1.35 — trading 17.4% above its estimated fair value. The current Gross Margin % is 70.25%, which is 26% above median its 10-year median of 55.95 and 45% above the Drug Manufacturers industry median of 48.44. Healthy Extracts' overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Healthy Extracts (HYEX), the current Gross Margin % is 70.25% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Healthy Extracts (HYEX) Overvalued in 2026?
Based on GuruFocus' analysis, Healthy Extracts stock appears to be overvalued.
The current stock price of $1.35 is trading 17.4% above its estimated GF Value™ of $1.15.
GuruFocus considers Healthy Extracts to be Modestly Overvalued.
Key valuation signals for HYEX:
Gross Margin %: 70.25% (26% above median its 10-year median of 55.95)
GF Value™: $1.15 vs. price of $1.35 (17.4% above fair value)
Industry Position: 45% above the Drug Manufacturers median (#281 of 938)
No single metric tells the full story. See the HYEX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Healthy Extracts Inc through its subsidiaries is engaged in proprietary research and development of natural plant-based formulations, manufacturing, sales, and distribution of cardiovascular and neuro products that provide natural brain solutions. The company also provides superfruit supplements to support overall cholesterol, metabolic and cardiovascular health. Its products are distributed in the United States and Mexico. Its operating segment includes, Health Supplements and Corporate. The company generates maximum revenue from the Health Supplements segment.
56GF Score
Get the complete analysis for HYEX
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HYEX has been successfully added to your 
